Thyroid cancer: open trials in Hong Kong SAR China

• NCT05786924

  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Trial Treatment · Phase 1/2 · Institut de Recherches Internationales Servier

  Queen Mary Hospital, Hong Kong · Prince of Wales, Shatin

  Registry updated 2026-10-13

• NCT07234539

  Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management

  Trial Treatment · The University of Hong Kong

  School of Public Health, The University of Hong Kong, Hong Kong · Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong

  Registry updated 2026-07-21

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Hong Kong · Hong Kong

  Registry updated 2026-05-27

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error